Cognitive Processing Therapy for Post Traumatic Stress Disorder (PTSD)
Phase-Based Progress Estimates
Effectiveness
Safety
Post Traumatic Stress Disorder (PTSD)
Cognitive Processing Therapy - BehavioralEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This trial is designed to compare the effectiveness of 1-week virtual massed Cognitive Processing Therapy (CPT) to 5-day virtual relaxation training (RT) with regard to their ability to reduce posttraumatic stress disorder (PTSD) symptoms.
Treatment Effectiveness
Effectiveness Progress
Other trials for Post Traumatic Stress Disorder (PTSD)
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: Through study completion, an average of 8 months
Month 8
Clinician-Administered PTSD Scale for DSM
PTSD Checklist for DSM-5 Criteria
Trial Safety
Safety Progress
Other trials for Post Traumatic Stress Disorder (PTSD)
Trial Design
2 Treatment Groups
Relaxation Training (RT)
1 of 2
Cognitive Processing Therapy (CPT)
1 of 2
Active Control
Experimental Treatment
140 Total Participants · 2 Treatment Groups
Primary Treatment: Cognitive Processing Therapy · No Placebo Group · N/A
Cognitive Processing Therapy (CPT)
Behavioral
Experimental Group · 1 Intervention: Cognitive Processing Therapy · Intervention Types: BehavioralRelaxation Training (RT)
Behavioral
ActiveComparator Group · 1 Intervention: Relaxation Training · Intervention Types: BehavioralTreatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Processing Therapy
2016
N/A
~2320
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of 8 months
Who is running the clinical trial?
Rush University Medical CenterLead Sponsor
379 Previous Clinical Trials
150,957 Total Patients Enrolled
8 Trials studying Post Traumatic Stress Disorder (PTSD)
517 Patients Enrolled for Post Traumatic Stress Disorder (PTSD)
Eligibility Criteria
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments